Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116925212 | 11692521 | 2 | F | 20160622 | 20151103 | 20160718 | PER | US-PFIZER INC-2015369933 | PFIZER | 68.00 | YR | F | Y | 66.00000 | KG | 20160718 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116925212 | 11692521 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | Y | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 116925212 | 11692521 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | Y | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 116925212 | 11692521 | 3 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 UNK, UNK | Y | Z911P | 20753 | 25 | MG | COATED TABLET | QD | ||||
| 116925212 | 11692521 | 4 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | 13 ?G, UNK | 0 | 13 | UG | TABLET | ||||||||
| 116925212 | 11692521 | 5 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 175 UG, 1X/DAY (BEFORE BREAKFAST) | 0 | 175 | UG | TABLET | QD | ||||||
| 116925212 | 11692521 | 6 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 1 MG, 1X/DAY (NIGHTLY) | 0 | 1 | MG | TABLET | QD | ||||||
| 116925212 | 11692521 | 7 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
| 116925212 | 11692521 | 8 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 75 MG, 1X/DAY (NIGHTLY) | 0 | 75 | MG | TABLET | QD | ||||||
| 116925212 | 11692521 | 9 | C | MINOCYCLINE | MINOCYCLINEMINOCYCLINE HYDROCHLORIDE | 1 | 100 MG, UNK | 0 | 100 | MG | TABLET | ||||||||
| 116925212 | 11692521 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 1000 IU, UNK | 0 | 1000 | IU | CAPSULE | ||||||||
| 116925212 | 11692521 | 11 | C | RISEDRONATE SODIUM. | RISEDRONATE SODIUM | 1 | Oral | 35 MG, WEEKLY | 0 | 35 | MG | TABLET | /wk | ||||||
| 116925212 | 11692521 | 12 | C | MINOCYCLINE | MINOCYCLINEMINOCYCLINE HYDROCHLORIDE | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116925212 | 11692521 | 1 | Breast cancer |
| 116925212 | 11692521 | 2 | Hormone level abnormal |
| 116925212 | 11692521 | 4 | Thyroid disorder |
| 116925212 | 11692521 | 6 | Sleep disorder |
| 116925212 | 11692521 | 7 | Sleep disorder |
| 116925212 | 11692521 | 11 | Osteoporosis |
| 116925212 | 11692521 | 12 | Rosacea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116925212 | 11692521 | Condition aggravated | |
| 116925212 | 11692521 | Hot flush | |
| 116925212 | 11692521 | Insomnia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116925212 | 11692521 | 1 | 20140825 | 0 | ||
| 116925212 | 11692521 | 2 | 20150424 | 0 | ||
| 116925212 | 11692521 | 3 | 2016 | 0 | ||
| 116925212 | 11692521 | 4 | 20140403 | 0 | ||
| 116925212 | 11692521 | 6 | 20140403 | 0 | ||
| 116925212 | 11692521 | 7 | 20140403 | 0 | ||
| 116925212 | 11692521 | 9 | 20140403 | 0 | ||
| 116925212 | 11692521 | 10 | 20140425 | 0 | ||
| 116925212 | 11692521 | 11 | 2015 | 0 |